CKD-383 clinical trials
Also written CKD-383.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2021
How each study uses CKD-383 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- CKD-383
- 5
Studies by the year they started
5 studies that test it; most in 2023 (2)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Studies
Open first, then newest update. How each study uses CKD-383 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy VolunteersCompletedPhase 1Chong Kun Dang PharmaceuticalNCT06695572Written as CKD-383
- Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy VolunteersCompletedPhase 1Chong Kun Dang PharmaceuticalNCT06695598Written as CKD-383
- Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029CompletedPhase 1Chong Kun Dang PharmaceuticalNCT05897216Written as CKD-383
- Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150CompletedPhase 1Chong Kun Dang PharmaceuticalNCT05816759Written as CKD-383
- A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.CompletedPhase 1Chong Kun Dang PharmaceuticalNCT04810676Written as CKD-383